Multi-Billion Dollar Potential: Deep Dive into FAPI Inhibitor Market Drivers and Challenges
The Fibroblast Activation Protein Inhibitor (FAPI) market is on the cusp of an explosive growth phase, driven by a confluence of technological advancement and a high unmet clinical need in oncology. FAP is a protein overexpressed on cancer-associated fibroblasts (CAFs) and is integral to the tumor microenvironment (TME), which facilitates tumor proliferation, invasion, and resistance to...
0 Комментарии 0 Поделились 8 Просмотры 0 предпросмотр